Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Helen Waller-Evans is active.

Publication


Featured researches published by Helen Waller-Evans.


Developmental Cell | 2009

Latrophilin Signaling Links Anterior-Posterior Tissue Polarity and Oriented Cell Divisions in the C. elegans Embryo

Tobias Langenhan; Simone Prömel; Behrooz Esmaeili; Helen Waller-Evans; Christian Hennig; Yuji Kohara; Leon Avery; Ioannis Vakonakis; Ralf Schnabel; Andreas P. Russ

Understanding the mechanisms that coordinate the orientation of cell division planes during embryogenesis and morphogenesis is a fundamental problem in developmental biology. Here we show that the orphan receptor lat-1, a homolog of vertebrate latrophilins, plays an essential role in the establishment of tissue polarity in the C. elegans embryo. We provide evidence that lat-1 is required for the alignment of cell division planes to the anterior-posterior axis and acts in parallel to known polarity and morphogenesis signals. lat-1 is a member of the Adhesion-GPCR protein family and is structurally related to flamingo/CELSR, an essential component of the planar cell polarity pathway. We dissect the molecular requirements of lat-1 signaling and implicate lat-1 in an anterior-posterior tissue polarity pathway in the premorphogenesis stage of C. elegans development.


PLOS ONE | 2010

The Orphan Adhesion-GPCR GPR126 Is Required for Embryonic Development in the Mouse

Helen Waller-Evans; Simone Prömel; Tobias Langenhan; John Dixon; Dirk Zahn; William H. Colledge; Joanne Doran; Mark B. L. Carlton; Ben Davies; Samuel Aparicio; Johannes Grosse; Andreas P. Russ

Adhesion-GPCRs provide essential cell-cell and cell-matrix interactions in development, and have been implicated in inherited human diseases like Usher Syndrome and bilateral frontoparietal polymicrogyria. They are the second largest subfamily of seven-transmembrane spanning proteins in vertebrates, but the function of most of these receptors is still not understood. The orphan Adhesion-GPCR GPR126 has recently been shown to play an essential role in the myelination of peripheral nerves in zebrafish. In parallel, whole-genome association studies have implicated variation at the GPR126 locus as a determinant of body height in the human population. The physiological function of GPR126 in mammals is still unknown. We describe a targeted mutation of GPR126 in the mouse, and show that GPR126 is required for embryonic viability and cardiovascular development.


Developmental Dynamics | 2012

Characterization and Functional Study of a Cluster of Four Highly Conserved Orphan Adhesion-GPCR in Mouse

Simone Prömel; Helen Waller-Evans; John Dixon; Dirk Zahn; William H. Colledge; Joanne Doran; Mark B. L. Carlton; Johannes Grosse; Torsten Schöneberg; Andreas P. Russ; Tobias Langenhan

Background: Adhesion G protein‐coupled receptors (aGPCR) constitute a structurally and functionally diverse class of seven‐transmembrane receptor proteins. Although for some of the members important roles in immunology, neurology, as well as developmental biology have been suggested, most receptors have been poorly characterized. Results: We have studied evolution, expression, and function of an entire receptor group containing four uncharacterized aGPCR: Gpr110, Gpr111, Gpr115, and Gpr116. We show that the genomic loci of these four receptors are clustered tightly together in mouse and human genomes and that this cluster likely derives from a single common ancestor gene. Using transcriptional profiling on wild‐type and knockout/LacZ reporter knockin mice strains, we have obtained detailed expression maps that show ubiquitous expression of Gpr116, co‐expression of Gpr111 and Gpr115 in developing skin, and expression of Gpr110 in adult kidney. Loss of Gpr110, Gpr111, or Gpr115 function did not result in detectable defects, indicating that genes of this aGPCR group might function redundantly. Conclusions: The aGPCR cluster Gpr110, Gpr111, Gpr115, and Gpr116 developed from one common ancestor in vertebrates. Expression suggests a role in epithelia, and one can speculate about a possible redundant function of GPR111 and GPR115. Developmental Dynamics 241:1591–1602, 2012.


PLOS ONE | 2013

Nutrigenomics of High Fat Diet Induced Obesity in Mice Suggests Relationships between Susceptibility to Fatty Liver Disease and the Proteasome

Helen Waller-Evans; Christophe Hue; Jane Fearnside; Alice R. Rothwell; Helen Lockstone; S. Calderari; Steven P. Wilder; Jean-Baptiste Cazier; James Scott; Dominique Gauguier

Nutritional factors play important roles in the etiology of obesity, type 2 diabetes mellitus and their complications through genotype x environment interactions. We have characterised molecular adaptation to high fat diet (HFD) feeding in inbred mouse strains widely used in genetic and physiological studies. We carried out physiological tests, plasma lipid assays, obesity measures, liver histology, hepatic lipid measurements and liver genome-wide gene transcription profiling in C57BL/6J and BALB/c mice fed either a control or a high fat diet. The two strains showed marked susceptibility (C57BL/6J) and relative resistance (BALB/c) to HFD-induced insulin resistance and non alcoholic fatty liver disease (NAFLD). Global gene set enrichment analysis (GSEA) of transcriptome data identified consistent patterns of expression of key genes (Srebf1, Stard4, Pnpla2, Ccnd1) and molecular pathways in the two strains, which may underlie homeostatic adaptations to dietary fat. Differential regulation of pathways, including the proteasome, the ubiquitin mediated proteolysis and PPAR signalling in fat fed C57BL/6J and BALB/c suggests that altered expression of underlying diet-responsive genes may be involved in contrasting nutrigenomic predisposition and resistance to insulin resistance and NAFLD in these models. Collectively, these data, which further demonstrate the impact of gene x environment interactions on gene expression regulations, contribute to improved knowledge of natural and pathogenic adaptive genomic regulations and molecular mechanisms associated with genetically determined susceptibility and resistance to metabolic diseases.


PLOS ONE | 2014

Genetic Control of Differential Acetylation in Diabetic Rats

Pamela J. Kaisaki; Georg W. Otto; Joanna F. McGouran; Amine Toubal; Karène Argoud; Helen Waller-Evans; Clare Finlay; S. Calderari; Marie-Thérèse Bihoreau; Benedikt M. Kessler; Dominique Gauguier; Richard Mott

Post-translational protein modifications such as acetylation have significant regulatory roles in metabolic processes, but their relationship to both variation in gene expression and DNA sequence is unclear. We address this question in the Goto-Kakizaki (GK) rat inbred strain, a model of polygenic type 2 diabetes. Expression of the NAD-dependent deacetylase Sirtuin-3 is down-regulated in GK rats compared to normoglycemic Brown Norway (BN) rats. We show first that a promoter SNP causes down-regulation of Sirtuin-3 expression in GK rats. We then use mass-spectrometry to identify proteome-wide differential lysine acetylation of putative Sirtuin-3 protein targets in livers of GK and BN rats. These include many proteins in pathways connected to diabetes and metabolic syndrome. We finally sequence GK and BN liver transcriptomes and find that mRNA expression of these targets does not differ significantly between GK and BN rats, in contrast to other components of the same pathways. We conclude that physiological differences between GK and BN rats are mediated by a combination of differential protein acetylation and gene transcription and that genetic variation can modulate acetylation independently of expression.


bioRxiv | 2017

Effects Of Curcumin Nanoformulations On Cellular Function In Niemann-Pick Disease Type C Astrocytes

Emily Maguire; Luke J. Haslett; Joanne L. Welton; Helen Waller-Evans; Jule Goike; Emily H. Clark; Harry R. Knifton; Ravin Shrestha; Kim Wager; Richard Webb; Emyr Lloyd-Evans

Niemann-Pick disease type C1 (NPC disease) is a neurodegenerative multi-lipid lysosomal storage disease caused by mutations in the NPC1 gene presenting with reduced lysosomal Ca2+ signalling and inhibited late endosome-lysosome transport. Elevating cytosolic Ca2+ levels in NPC cells has been shown to reduce lysosomal lipid storage. Treating Npc1-/- mice with the Ca2+ modulator curcumin led to reduced lipid storage, improved life expectancy and function. These studies led to reported utilisation of curcumin supplements by NPC disease families despite there being no clinical evidence of benefit and a report indicating no benefit of nanoformulated curcumin in Npc1-/- mice. The aim of this study was to determine whether various commercially available curcumin nanoformulations were capable of reproducing the findings obtained with unformulated pharmaceutical grade curcumin. We compared seven curcumin nanoformulations in Npc1-/- mouse astrocytes. All the nanoformulations elevate cytosolic Ca2+ levels but only two lowered lysosomal lipid storage. Importantly, some caused elevations in NPC lysosomal storage and/or decreased cellular viability. Although this is an in vitro study, our findings suggest that care should be taken when contemplating the use of curcumin supplements for NPC disease.


Biochemical Society Transactions | 2010

Endolysosomal calcium regulation and disease.

Emyr Lloyd-Evans; Helen Waller-Evans; Ksenia Peterneva; Frances M. Platt


Biochemical Society Transactions | 2015

Regulation of TRPML1 function

Helen Waller-Evans; Emyr Lloyd-Evans


Molecular Genetics and Metabolism | 2018

Simple fluorimetric test for lysosomal swelling as a means to identify, monitor and develop therapies for all lysosomal diseases

Abdullah S. Alshehri; Luke J. Haslett; Helen Waller-Evans; Emyr Lloyd-Evans


American Journal of Human Genetics | 2018

Bi-allelic CCDC47 Variants Cause a Disorder Characterized by Woolly Hair, Liver Dysfunction, Dysmorphic Features, and Global Developmental Delay

Marie Morimoto; Helen Waller-Evans; Zineb Ammous; Xiaofei Song; Kevin A. Strauss; Davut Pehlivan; Claudia Gonzaga-Jauregui; Erik G. Puffenberger; Charles R. Holst; Ender Karaca; Karlla W. Brigatti; Emily Maguire; Zeynep Coban-Akdemir; Akiko Amagata; C. Christopher Lau; Xenia Chepa-Lotrea; Ellen F. Macnamara; Tulay Tos; Sedat Işıkay; Michele E. Nehrebecky; John D. Overton; Matthew Klein; Thomas C. Markello; Jennifer E. Posey; David Adams; Emyr Lloyd-Evans; James R. Lupski; William A. Gahl; May Christine V. Malicdan

Collaboration


Dive into the Helen Waller-Evans's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dirk Zahn

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Joanne Doran

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Johannes Grosse

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

John Dixon

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge